|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1993-1-6
|
|
pubmed:abstractText |
A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0939-1983
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
306-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1450710-Adolescent,
pubmed-meshheading:1450710-Adult,
pubmed-meshheading:1450710-Biopsy,
pubmed-meshheading:1450710-Chronic Disease,
pubmed-meshheading:1450710-Female,
pubmed-meshheading:1450710-Hepatitis D,
pubmed-meshheading:1450710-Humans,
pubmed-meshheading:1450710-Interferon Type I,
pubmed-meshheading:1450710-Liver,
pubmed-meshheading:1450710-Male,
pubmed-meshheading:1450710-Middle Aged,
pubmed-meshheading:1450710-Recombinant Proteins,
pubmed-meshheading:1450710-Treatment Outcome
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.
|
|
pubmed:affiliation |
Lazzaro Spallanzani Hospital for Infectious Diseases, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
